This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Kyung-Seok Oh: Innovator in Pharmaceutical Chemistry
Introduction
Kyung-Seok Oh is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications.
Latest Patents
Kyung-Seok Oh holds a patent for a compound titled "5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof." This invention provides a novel derivative of 5-carbamoyl adamantan-2-yl amide, or a pharmaceutically acceptable salt thereof, which is used for inhibiting the activity of 11β-hydroxysteroid dehydrogenase type 1 (11b-HSD1). The compound has potential applications in preventing and treating various diseases mediated by this enzyme.
Career Highlights
Kyung-Seok Oh is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to advance his research and development efforts in the pharmaceutical sector. His work focuses on innovative solutions that address critical health challenges.
Collaborations
He has collaborated with notable colleagues, including Choon-Ho Ryu and Seon-Jeong Lee, to further enhance the impact of his research and inventions.
Conclusion
Kyung-Seok Oh's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing new therapeutic agents. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile